SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending as the company maintains its full-year guidance and exhibits strong resilience in engine flight hours, effectively mitigating regional disruptions while benefiting from robust defense and power generation backlogs. Investors are actively discussing the companys ongoing nuclear and SMR expansion, potential multi-billion dollar contracts in Europe and India, and a successful transformation into a high-margin industrial leader.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is gaining traction as investors anticipate the upcoming launch of predictive allocation mechanics and an expansion to the Ethereum mainnet. The community is actively debating the protocol's long-term utility as core infrastructure for the Base ecosystem while discussing potential price movements amid broader market volatility.

Ambiq Micro, Inc. engages in the provision of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI computing. It operates through the following geographical segments: China, Taiwan, Singapore, and Rest of the World. The company was founded by Scott Hanson, Dennis Sylvester, and David Blaauw on January 20, 2010 and is headquartered in Austin, TX.

Ambiq Micro Inc.

Ambiq Micro, Inc.

Ambiq Micro is trending as investors bet on the company's ultra-low-power semiconductor technology to become a critical component for the rapidly expanding edge AI and wearable device markets. The community is buzzing over its potential for long-term growth and technical breakout, with many active participants focused on the stock's role as a niche infrastructure play alongside major AI hardware leaders.

Harvest Portfolios Group Inc - Harvest Diversified High Income Shares ETF (Class A Units)

The Harvest Diversified High Income Shares ETF is seeing active interest as investors evaluate how Canadian ETFs with U.S. exposure navigate market holidays and adjust for changing portfolio weightings. Community discussion is focused on the fund's role in monthly income-compounding strategies, particularly as investors rotate capital from other high-yield products to capitalize on dividend snowball effects.

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire &amp; inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

401jK is gaining attention as a 'pure belief' meme asset that promotes a retirement alternative through a community-driven, anti-establishment narrative. Proponents are highlighting the upcoming NFT drop on Magic Eden and the project's 'Resist & Retire' messaging as key drivers for their long-term conviction.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound is currently facing intense selling pressure and volatility following reports of a class-action lawsuit filed against the protocol's DAO, compounding frustrations among community members over recent performance and governance concerns. While some investors interpret the sharp decline as a generational buying opportunity near all-time lows, others are actively debating the long-term viability of the project and comparing its fundamental metrics to more resilient DeFi peers.

ROAM Token

Roam is gaining momentum as a leading DePIN infrastructure project, with the community highlighting its focus on real-world utility like eSIM connectivity and its expanding global node network. Investors and participants are actively engaging with the ecosystem through creative reward campaigns and the ongoing integration of autonomous AI agents that rely on the network's foundational infrastructure.

The Render Network is a leading decentralized GPU compute platform for applications ranging from 3D rendering to machine learning and generative AI.  The network connects node operators looking to monetize their idle GPU compute power with artists and developers looking to scale intensive 3D rendering work and machine learning applications in the cloud. Through a decentralized peer-to-peer network, the Render Network achieves unprecedented levels of scale, speed, and economic efficiency. Facilitated by the Render Network Foundation, the ecosystem empowers artists and developers to build services and applications for the emerging digital economy.

Render Token (SOL)

Render (RENDER) is trending as investors focus on its role as a key infrastructure play within the DePIN and decentralized AI sectors, viewing it as essential utility for future compute demands. While some retail traders express frustration with recent price consolidation and volatility, the community is actively debating its long-term potential compared to other AI-focused projects, with many favoring it as a foundational asset to accumulate.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

GSK Plc - ADR

Glaxosmithkline plc - ADR

GlaxoSmithKline (GSK) is capturing community attention as investors closely monitor its pipeline development and potential for near-term strategic acquisitions to bolster its long-term growth targets. Discussion is particularly focused on how these activities could offset vaccine-related headwinds and leverage strong performance across its specialty medicines and oncology portfolios.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is drawing significant attention as investors react to ongoing crypto regulation debates, specifically surrounding the potential passage of the Clarity Act. Market participants are closely monitoring high-volume institutional movements and options activity as the ETF trades near key technical levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Plus Therapeutics (PSTV) Reports Q1 Loss, Tops Revenue Estimates

Plus (PSTV) delivered earnings and revenue surprises of -11.11% and +8.21%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings and Revenue Estimates

Catalyst (CPRX) delivered earnings and revenue surprises of +23.44% and +1.57%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

OmniAb, Inc. (OABI) Reports Q1 Loss, Tops Revenue Estimates

OmniAb, Inc. (OABI) delivered earnings and revenue surprises of +40.00% and +164.13%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

PSTV Stock On Track For Best Week Since September — Here’s What Is Driving The Rally

Equity

Earlier this week, Plus Therapeutics said that the FDA has granted Orphan Drug Designation to its experimental drug REYOBIQ for the treatment of pediatric malignant gliomas. 


Why Is Plus Therapeutics Stock Gaining Friday?

Plus Therapeutics stock jumps after FDA grants Orphan Drug status to Reyobiq for pediatric brain cancer, boosting long-term outlook.read more...

Plus Therapeutics (NASDAQ:PSTV) Stock Price Down 9.9% - Here's Why

Plus Therapeutics (NASDAQ:PSTV) Stock Price Down 9.9% - Here's What Happened...

Plus Therapeutics (PSTV) Reports Break-Even Earnings for Q4

Plus (PSTV) delivered earnings and revenue surprises of +100.00% and +2.02%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates

Nektar (NKTR) delivered earnings and revenue surprises of +35.47% and +128.59%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Guardian Pharmacy Services (GRDN) Surpasses Q4 Earnings and Revenue Estimates

Guardian Pharmacy (GRDN) delivered earnings and revenue surprises of +37.04% and +2.41%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q4 Loss, Beats Revenue Estimates

CRINETICS PHARM (CRNX) delivered earnings and revenue surprises of +6.01% and +38.05%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

Plus Therapeutics Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

PSTVPlus Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PSTV News